Login to Your Account

U.S. Patent Disclosures

Wednesday, January 19, 2011
Omni Bio Pharmaceutical Inc., of Denver, has received U.S. Patent No. 7,807,781 titled "Inhibitors of Serine Protease Activity and Their Use in Methods and Compositions for Treatment of Viral Infections."

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription